A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of PF-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control

Trial Profile

A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of PF-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Jan 2017

At a glance

  • Drugs PF 6372865 (Primary) ; Naproxen
  • Indications Back pain
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 15 Oct 2015 Status changed from discontinued to completed as reported by ClinicalTrials.gov record.
    • 14 Aug 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Nov 2015 to 1 Aug 2015.
    • 14 Aug 2015 According to the ClinicalTrials.gov record, primary completion date changed from 1 Nov 2015 to 1 Aug 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top